loadpatents
Patent applications and USPTO patent grants for Bionoxx Inc..The latest application filed is for "pharmaceutical composition comprising vaccinia virus and hydroxyurea as active ingredient for treatment of cancer".
Patent | Date |
---|---|
Pharmaceutical Composition Comprising Vaccinia Virus And Hydroxyurea As Active Ingredient For Treatment Of Cancer App 20220304960 - Hwang; Tae-Ho ;   et al. | 2022-09-29 |
Pharmaceutical Composition For Treating Cancer, Comprising Vaccinia Virus And Granulopoiesis Inhibitor As Active Ingredients App 20220288143 - Hwang; Tae-Ho ;   et al. | 2022-09-15 |
Oncolytic Virus With Improved Safety And Anticancer Effects App 20220202885 - HWANG; Taeho ;   et al. | 2022-06-30 |
Oncolytic Virus Improved In Safety And Anticancer Effect App 20210060103 - HWANG; Taeho ;   et al. | 2021-03-04 |
Pharmaceutical Composition For Preventing Or Treating Cancer Comprising Anticancer Virus And Hydroxyurea As Effective Components App 20200405794 - HWANG; Tae-Ho ;   et al. | 2020-12-31 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.